Moneycontrol PRO
UPCOMING EVENT:Join us for New HorAIzon from Oct 6-7, 2pm and be a part of exciting conversations on tech & innovation

Sun Pharma Adv Standalone June 2021 Net Sales at Rs 21.99 crore, down 88.14% Y-o-Y

July 27, 2021 / 11:36 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Sun Pharma Advanced Research Company are:

Net Sales at Rs 21.99 crore in June 2021 down 88.14% from Rs. 185.45 crore in June 2020.

Quarterly Net Loss at Rs. 61.37 crore in June 2021 down 208.26% from Rs. 56.69 crore in June 2020.

EBITDA stands negative at Rs. 53.47 crore in June 2021 down 187.03% from Rs. 61.44 crore in June 2020.

Sun Pharma Adv shares closed at 260.45 on July 26, 2021 (NSE) and has given 41.51% returns over the last 6 months and 53.25% over the last 12 months.

Close
Sun Pharma Advanced Research Company
Standalone Quarterly Resultsin Rs. Cr.
Jun'21Mar'21Jun'20
Net Sales/Income from operations21.9928.06185.45
Other Operating Income------
Total Income From Operations21.9928.06185.45
EXPENDITURE
Consumption of Raw Materials2.872.186.24
Purchase of Traded Goods------
Increase/Decrease in Stocks------
Power & Fuel------
Employees Cost25.5222.1024.00
Depreciation2.532.602.78
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses47.8754.2194.43
P/L Before Other Inc. , Int., Excpt. Items & Tax-56.80-53.0358.00
Other Income0.800.330.66
P/L Before Int., Excpt. Items & Tax-56.00-52.7058.66
Interest5.374.021.97
P/L Before Exceptional Items & Tax-61.37-56.7256.69
Exceptional Items------
P/L Before Tax-61.37-56.7256.69
Tax------
P/L After Tax from Ordinary Activities-61.37-56.7256.69
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period-61.37-56.7256.69
Equity Share Capital26.2126.2126.21
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS-2.34-2.162.16
Diluted EPS-2.34-2.162.16
EPS After Extra Ordinary
Basic EPS-2.34-2.162.16
Diluted EPS-2.34-2.162.16
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark